Home > PJ > Contents

The Pharmaceutical Journal, November 10, 2001

Back issues

Previous  Next

Return to PJ Online Home Page

Leading Article   
   Supervision debate will run and run

News & Features   
   News (including news in brief)
   NICE and MS: The saga will continue [more]
   How pharmacists help speed up the discharge process to release beds [more]

Letters   
   Letters to the Editor

Continuing education   
   Motor neurone disease: (1) Clinical features and pathogenesis
   »(PDF*, 55K)

Original papers   
   A pharmacy workforce survey in the West Midlands: (4) Morale and motivation
   »(PDF*, 85K)

Articles   
   Fasting during Ramadan: a Muslim pharmacist's perspective [more]
   Ethical issues surrounding clinical trials in community pharmacies
   »(PDF*, 55K)

Onlooker

The Society   
   Policy development in the Society [more]
   PDG conference 19/Nov [more]

Notice-board
   Branch meetings
   Future events
   Health promotions
   Conferences
and more

Products


  * PDF files on PJ Online require Acrobat Reader 4 or later.


Front Cover Picture
This week’s front cover picture (The Image Bank/Getty Images) shows a Muslim reading the Koran. An article this week explains why Muslims fast during the holy month of Ramadan and offers advice on medicines and diet during fasting.

Immunisation for Haj
The need for pilgrims to Mecca to be immunised against meningitis is highlighted.

Multiple sclerosis
The National Institute for Clinical Excellence has published the final consultation document of its appraisal on beta-interferon and glatiramer acetate for multiple sclerosis. A news feature this week finds out what the document says and how people are responding to it.

Motor neurone disease
In our continuing education article, the main clinical features, diagnostic criteria and pathogenesis of motor neurone disease are described.

Morale and motivation
Research published this week shows that although many pharmacists are satisfied with their career and current role, large numbers of pharmacists are dissatisfied.

Recall
Eli Lilly has recalled all batches of Kefadim (ceftazidime) 500mg, 1g and 2g injections (p675).


©The Pharmaceutical Journal